Resources and insights

Albuquerque, NMEquiSeq today disclosed the genes affected by the P2, P3, and P4 genetic variants that are part of its Myopathy Panel. The genetic variants are in part responsible for Polysaccharide Storage Myopathy type 2 (PSSM2), also known as Myofibrillar Myopathy (MFM). The genes affected by the P2, P3, and P4 genetic variants were disclosed at a poster presentation at the 2018 BioVenture Partnership Event at the University of New Mexico on March 7.The P2 genetic variant affects MYOT, the gene encoding myotilin. The P2 variant is a missense allele that causes a nonconservative amino acid substitution in a highly conserved position in the myotilin protein. Myotilin is an actin-binding protein that is part of the Z disc, the part of the sarcomere to which actin thin filaments are anchored. Mutations in human myotilin are the cause of Myofibrillar Myopathy 3 and Limb-Girdle Muscular Dystrophy 1A.The P3 genetic variant affects FLNC, the gene encoding filamin C. The P3 genetic variant is a pair of missense alleles that cause two nonconservative amino acid substitutions in highly conserved positions in the filamin C protein. Filamin C is a muscle-specific member of the filamin family, an actin-binding protein that is also part of…

EquiSeq is conducting a study of the effect of myopathy variants (P2, P3, and P4) on Thoroughbred performance. We seek registered Thoroughbreds of any age for this study. To have your Thoroughbred included in the study, you must be a horse owner in the United States with one or more registered Thoroughbreds. Your Thoroughbred must be included in the Pedigree Online Thoroughbred Database. You must be willing to submit a 10 ml EDTA blood draw at EquiSeq’s expense. We will cover all costs, including vet fees. If your horse is selected for the study, you will receive results for P2, P3, P4, and Px at no cost to you. If you have a horse that meets these criteria, please email Paul Szauter at pszauter@gmail.com. Please feel free to share this message. Free testing for registered Thoroughbreds will end on September 1, 2018. Thoroughbred owners who have initiated contact with EquiSeq prior to that time will receive free testing.

ALBUQUERQUE, N.M. Albuquerque startup EquiSeq dominated the slopes this year at the third annual ski lift pitch competition, beating out 11 other companies to win a $10,000 prize at the Taos Ski Valley on Tuesday. The competition, organized by Albuquerque’s ABQid business accelerator, is a novel twist on pitch competitions that places competing companies on Taos Valley’s Kachina Peak Lift alongside investors and entrepreneurs who judge their business presentations while riding up the slopes. Continue Reading »

Episode 2 of Startup Spot with Sonja, I interview Paul Szauter, Chief Scientific Officer, and Lexie Palmer, CEO of Equiseq. Hear about how their business is changing after researching their original direction. Continue Reading »

EquiSeq is developing a test to determine whether a foal has a specific gene that causes a fatal muscle malady within the first few years of life. Continue Reading »

The room was packed, the wait staff was bustling around serving the 80+ attendees. There was electricity in the air. Then the pitches started and the energy level went through the roof. Was it because of the amazing food at Standard Diner? Was it because the judges had been drinking? Was it because of the great prizes that were annouced (over $1250)? Was it the additional prizes for Trivia answers provided by CNM? Was it the comedy team of Nyika Allen and Lisa Adkins from the New Mexico Tech council with their set of Entrepreneurial jokes? Was the the eleven brave, nervous, anxious presenters? Continue Reading »

Last Friday was the ABQid Demo Day and it was a packed house at the Epicenter. I rarely get to see these type of activities, but my wife let me use some of my paternity leave to check it out. The energy and excitement of these events blows me away every time. The presenters, sponsors and audience create an atmosphere that makes it real easy to believe a lot of great things are happening and going to be happening in Albuquerque. This event allowed the 10 companies from the second ABQid accelerator class to pitch their company in 6 minutes. They all did a great job on their pitches and I feel lucky to have gotten to watch this. Continue Reading »

Paul Szauter of EquiSeq pitched his company to the crowd at Epicenter on ABQid Demo Day on August 28, 2015.  Watch Video » Continue Reading »

Paul Szauter says he’s getting his pitch together “to get a second date,” with some of the investors that will be in the crowd at the ABQid Demo Day. Demo Day for ABQid is still two weeks away, but the CEOs are just now putting the final touches on their six-minute pitches for the event. Continue Reading »

New Mexico Technology Council and ABQid hosted a Scrappy Startup Challenge where 11 entrepreneurs pitched their ideas in front of a panel of venture capitalists/judges.  The catch, they only had 3 minutes to sell their product and idea. Here are the winners of the competition… Continue Reading »